GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (CHIX:EVEz) » Definitions » EV-to-Revenue

Evolva Holding (CHIX:EVEZ) EV-to-Revenue : 1.60 (As of May. 15, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Evolva Holding EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Evolva Holding's enterprise value is CHF18.93 Mil. Evolva Holding's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was CHF11.86 Mil. Therefore, Evolva Holding's EV-to-Revenue for today is 1.60.

The historical rank and industry rank for Evolva Holding's EV-to-Revenue or its related term are showing as below:

CHIX:EVEz' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.81   Med: 13.08   Max: 47.52
Current: 1.59

During the past 13 years, the highest EV-to-Revenue of Evolva Holding was 47.52. The lowest was 0.81. And the median was 13.08.

CHIX:EVEz's EV-to-Revenue is ranked better than
83.72% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs CHIX:EVEz: 1.59

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Evolva Holding's stock price is CHF0.946. Evolva Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF2.65. Therefore, Evolva Holding's PS Ratio for today is 0.36.


Evolva Holding EV-to-Revenue Historical Data

The historical data trend for Evolva Holding's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding EV-to-Revenue Chart

Evolva Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.43 11.73 20.20 13.50 6.53

Evolva Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.50 - 6.53 -

Competitive Comparison of Evolva Holding's EV-to-Revenue

For the Biotechnology subindustry, Evolva Holding's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Evolva Holding's EV-to-Revenue falls into.



Evolva Holding EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Evolva Holding's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=18.932/11.858
=1.60

Evolva Holding's current Enterprise Value is CHF18.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was CHF11.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding  (CHIX:EVEz) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Evolva Holding's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.946/2.652
=0.36

Evolva Holding's share price for today is CHF0.946.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was CHF2.65.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Evolva Holding's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding (CHIX:EVEZ) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding (CHIX:EVEZ) Headlines

No Headlines